Shannon Hardy
Obstetrics & Gynecology · Houston, TXNPI 1902097181
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 12.4% — the pattern of someone who eats at a lot of different presentations.
Across 119 payments — averaging $20.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$303
- AbbVie$200
- Evofem Biosciences, Inc.$185
- Myovant Sciences Inc.$179
- Hologic Sales And Service, LLC$159
- Sumitomo Pharma America, Inc.$141
- plus $1K from 21 others
What the payments were for
- Food & beverage$2,445100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 14 | $303 |
| AbbVie(2 entities) | 10 | $200 |
| Evofem Biosciences, Inc. | 9 | $185 |
| Myovant Sciences Inc. | 7 | $179 |
| Hologic Sales And Service, LLC | 7 | $159 |
| Sumitomo Pharma America, Inc. | 6 | $141 |
| Medtronic | 6 | $136 |
| Bayer | 6 | $132 |
| Mayne Pharma Commercial LLC | 4 | $124 |
| Avion Pharmaceuticals | 10 | $121 |
| Organon | 6 | $102 |
| Biogen | 4 | $97 |
| Exeltis, USA Inc. | 3 | $90 |
| Coopersurgical, Inc. | 5 | $82 |
| Pfizer | 5 | $79 |
| Covidien LP | 2 | $44 |
| Dexcom, Inc. | 2 | $36 |
| Optumhealth Care Solutions, LLC | 2 | $34 |
| Mylan Pharmaceuticals Inc. | 2 | $31 |
| Gynesonics, Inc. | 1 | $30 |
| Sage Therapeutics, LLC | 2 | $26 |
| Aspira Women's Health Inc | 1 | $23 |
| Exact Sciences | 1 | $21 |
| Agile Therapeutics, Inc. | 1 | $20 |
| Medicem Inc. | 1 | $18 |
| Lupin Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
How this compares
$2,445 in reported general payments places this provider in the 70th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 13 | $147 |
| Levothyroxine Sodium | 13 | $134 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Houston
- George KuhnHouston$244K
- Daisy AyimHouston$188K
- Shannon WestinHouston$176K
- Asha BhalwalHouston$151K
- Nicole TranHouston$133K
- Sandra HurtadoHouston$123K
- Alvaro MontealegreHouston$92K
- Patti RossHouston$72K
- Damla KarsanHouston$58K
- Christopher JayneHouston$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.